Showing 1 - 10 of 396
Novo Nordisk Addresses Economic Risks of Obesity on World Obesity Day
Published on 04/03/2026
» Thailand is among the countries worldwide battling non-communicable diseases (NCDs), with various control measures targeting dietary intake and lifestyle modification. However, the prevalence of overweight and obesity remains among the highest in Asean, with trends indicating a continued rise that threatens long-term public health and economic productivity. Though being regarded as a chronic disease, obesity treatment is not reimbursable underthe Thai public health coverage.
Drilling down on US tariff manoeuvres
Business, Somhatai Mosika, Published on 28/02/2026
» Global trade is grappling with uncertainties stemming from unpredictable US trade policy regarding tariffs. President Donald Trump has maintained his reliance on tariffs, aiming to reduce US imports, diminish the trade deficit, and revive American manufacturing.
AstraZeneca Launches “A.Catalyst Thailand Hub”: AI-Integrated Health Transformation
Published on 26/02/2026
» AstraZeneca (Thailand) Ltd., in collaboration with the public and private sectors, academia, and patient networks, has officially launched the A.Catalyst Network Thailand Hub. This global health innovation network aims to synergise cross-sector potential by leveraging artificial intelligence technology and digital solutions to advance proactive healthcare. The A.Catalyst Network Thailand Hub’s Honourable Advisers comprises experts from diverse fields dedicated to driving innovation for a sustainable healthcare future.
Aberdeen bullish on local equities post-election
Business, Nuntawun Polkuamdee, Published on 24/02/2026
» Aberdeen Asset Management has adopted a bullish stance on Thai equities following the recent election, noting political clarity and improving stability could pave the way for renewed foreign inflows and a recovery in the benchmark index to 1,500 points.
Trump boosts new tariff rate to 15% a day after announcing 10%
Bloomberg News, Published on 22/02/2026
» President Donald Trump said he will increase the global 10% tariff he announced one day earlier to 15%, stirring up more economic turbulence as he lashed out at the US Supreme Court over its ruling that his preferred mechanism for applying tariffs was illegal.
BJC, DHL unite on healthcare logistics
Business, Kuakul Mornkum, Published on 14/01/2026
» Berli Jucker Logistics, a subsidiary of Berli Jucker Plc (BJC), and DHL Supply Chain (Thailand) have announced the formation of a joint venture aiming to raise BJC Big C Group's logistics operations to global standards and accelerate growth in healthcare markets.
Trump signs order to ease cannabis limits in industry win
Bloomberg, Published on 19/12/2025
» President Donald Trump on Thursday signed an executive order directing his administration to move cannabis into a less restrictive federal category, setting in motion a regulatory shift that could alter the legal and commercial landscape for the drug nationwide.
Pact aims to rev up pharma patent use
Business, Phusadee Arunmas, Published on 11/12/2025
» The Department of Intellectual Property (DIP) held discussions with the Food and Drug Administration (FDA) to support the targeted development of health products. The collaboration aims to enhance health offerings to better serve an ageing society and address emerging diseases.
Innobic buys Alvogen Pharma
Business, Yuthana Praiwan, Published on 08/12/2025
» Innobic (Asia), the life science arm of energy giant PTT Plc, is moving into the world's largest pharmaceutical market after securing a foothold in the US through the acquisition of Alvogen Pharma US Inc.
India advances anti-dumping probe into tuberculosis drug imports from Thailand, China
Reuters, Published on 27/10/2025
» NEW DELHI - India on Monday advanced an anti-dumping investigation into imports from China and Thailand of Ethambutol Hydrochloride, an active pharmaceutical ingredient used in anti-tuberculosis drugs, by releasing a list of registered interested parties.